Personal Capital Advisors Corp Acquires Shares of 2,408 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Personal Capital Advisors Corp acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 2,408 shares of the exchange traded fund’s stock, valued at approximately $229,000.

A number of other large investors also recently modified their holdings of the business. FMR LLC increased its position in shares of SPDR S&P Biotech ETF by 5.7% during the 4th quarter. FMR LLC now owns 126,224 shares of the exchange traded fund’s stock valued at $12,005,000 after purchasing an additional 6,769 shares during the last quarter. Cullen Frost Bankers Inc. increased its holdings in SPDR S&P Biotech ETF by 459.6% in the 4th quarter. Cullen Frost Bankers Inc. now owns 291 shares of the exchange traded fund’s stock worth $28,000 after acquiring an additional 239 shares during the last quarter. Autus Asset Management LLC increased its holdings in SPDR S&P Biotech ETF by 3.3% in the 4th quarter. Autus Asset Management LLC now owns 52,100 shares of the exchange traded fund’s stock worth $4,956,000 after acquiring an additional 1,670 shares during the last quarter. Colony Group LLC purchased a new stake in SPDR S&P Biotech ETF in the 3rd quarter worth about $366,000. Finally, Weatherly Asset Management L. P. increased its holdings in SPDR S&P Biotech ETF by 4.5% in the 4th quarter. Weatherly Asset Management L. P. now owns 159,677 shares of the exchange traded fund’s stock worth $15,187,000 after acquiring an additional 6,913 shares during the last quarter.

XBI traded up $4.46 during trading hours on Friday, hitting $75.24. The stock had a trading volume of 16,284,239 shares, compared to its average volume of 6,451,152. The company’s fifty day simple moving average is $91.87 and its 200 day simple moving average is $87.90. SPDR S&P Biotech ETF has a 1 year low of $67.45 and a 1 year high of $98.79.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Recommended Story: Why does the United States have a lingering trade deficit?

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.